chartexchange

TMDX
TransMedics Group, Inc. Common Stock
stockNASDAQ

Market OpenNov 17, 2026 11:28:27 AM EST
92.94USD+0.792%(+0.73)275,812
Pre-marketNov 17, 2026 9:27:50 AM EST
92.06USD-0.163%(-0.15)
78.97Bid107.16Ask28.19Spread
Loading…
Loading…
Healthcare
Medical Devices
HQ
Andover, MA, USA
Previous Close
$92.23
Beta
1.20
52-Week High
$156.00 2025-12-02
52-Week Low
$60.11 2026-05-13
SMA 50
$80.33
SMA 200
$91.42
Avg. Vol 10D
1.59M
Avg. Vol 30D
1.11M
Avg. Vol 90D
920,001
Relative Vol
0.24
33.62M
0.2500%
412
TMDX Profile

transmedics inc. is the world's leader in portable ex-vivo perfusion and assessment of donor organs for transplantation. the company was founded to address the need for more and better organs for transplantation, and is focused on transforming the standard of care – increasing organ utilization, improving patient outcomes, and reducing transplant costs throughout the heath care system. the ocs™ lung and ocs™ heart systems are ce-marked and in commercial use outside the us, and are currently being reviewed by the fda for u.s. market access. the ocs™ liver is in an fda pivotal trial (the ocs™ liver protect trial) in the united states and a ce-mark trial in (the revive trial) in europe.

TMDX Performance
PeriodPriceDateChangeBeta
1W90.952026-11-10+2.26%0.098
1M70.782026-10-16+31.39%1.685
3M88.352026-08-17+5.26%1.624
6M68.342026-05-18+36.08%1.281
1Y113.402025-11-17-17.99%1.200
2Y80.932024-11-18+14.91%—
5Y23.872021-11-17+289.61%1.565
TMDX Stock Summary

TransMedics Group, Inc. Common Stock (NASDAQ:TMDX) stock price today is $93.00, and today's volume is 270,465. TMDX is up 0.857% today. The 30 day average volume is 1.11M. TMDX market cap is $3.23B with 34.73M shares outstanding.